This inventor holds 1 USPTO granted patent. Top assignee: Yale University. Active years: 2025.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2025
Title: Innovations of Albert DeBerardinis
Introduction
Albert DeBerardinis is a notable inventor based in New Haven, Connecticut. He has made significant contributions to the field of molecular biology, particularly in the area of intron splicing. His work focuses on developing methods to inhibit group II intron RNA, which has implications for treating various diseases.
Latest Patents
DeBerardinis holds a patent for "Compositions and methods for inhibiting group II intron RNA." This invention provides compositions and methods aimed at inhibiting group II intron splicing. The goal is to treat or prevent diseases associated with organisms harboring active group II introns. Additionally, the invention seeks to inhibit, prevent, or reduce the growth of such organisms.
Career Highlights
Albert DeBerardinis is affiliated with Yale University, where he conducts his research and development work. His innovative approaches have garnered attention in the scientific community, contributing to advancements in genetic research and therapeutic methods.
Collaborations
Some of his notable coworkers include Anna Marie Pyle and Olga Fedorova. Their collaborative efforts have further enhanced the research output and innovation in their respective fields.
Conclusion
Albert DeBerardinis exemplifies the spirit of innovation in molecular biology through his patent and research at Yale University. His work on inhibiting group II intron RNA represents a significant advancement in the quest for effective treatments for related diseases.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile